Enrico Velardi
banner
velardilab.bsky.social
Enrico Velardi
@velardilab.bsky.social
Translational Immunologist | Lab Head | Studying hematopoietic regeneration, immune reconstitution, thymus function, HSCT | Div. Hematology-Oncology @Bambino Gesu Children Hospital, Rome, 🇮🇹 https://velardilab.blogspot.com/
I’m pleased to share that I’ve been awarded an Independent Investigator Grant from @RallyFoundation for Childhood Cancer Research to support our research on regenerating #thymic function.

Grateful to be part of this mission.

Let’s #RallyOn and stay #GOLDSTRONG for every child and family affected.
May 6, 2025 at 8:47 AM
Just in time for #ASH24, our latest paper is out. We performed scRNA-seq on HSPCs over human development, maturation, and postnatal aging. We looked at dynamics of HSPC subsets, lineage biases, HSC level priming, and identified a developmentally restricted human HSC.
www.nature.com/articles/s41...
The dynamics of hematopoiesis over the human lifespan - Nature Methods
This Resource presents an atlas classifying the age-related changes in human hematopoietic stem and progenitor cells from gestation through aging.
www.nature.com
December 23, 2024 at 7:16 PM
Reposted by Enrico Velardi
Hello, #MedSky community! We’re excited to begin our Bluesky journey.

Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
December 6, 2024 at 8:24 PM
Our recently published work in collaboration with our neighbor gdT cell experts - Chiara Agrati Lab - on the antiviral activity of Vδ2 T cells in haplo-HCT recipients
pubmed.ncbi.nlm.nih.gov/39626282/
Antiviral potential of Vδ2 T-cells in children given TCR αβ/CD19 cell depleted HLA-haploidentical HSCT - PubMed
γδ T-cells represent key players in the immune-surveillance after TCR alpha/beta (αβ)/CD19-depleted HLA-Haploidentical Stem Cell Transplantation (haplo-HSCT). Although encouraging data are available o...
pubmed.ncbi.nlm.nih.gov
December 7, 2024 at 1:06 PM
Reposted by Enrico Velardi
Max deserves a Nobel. In the meantime, you can nominate someone for the Max Cooper Prize, deadline is April 1st.

"Nomination letters of up to 3 pages must articulate how their research has led to advances in immunology research that will have a lasting impact."
#Immunology
Emory Max Cooper Prize in Immunology | Emory School of MedicineToggleToggleToggleToggleSearchCloseSearch SearchToggle openToggle closeSub linkSub linkSub linkSub linkSub linkSub linkToggle openToggle ...
med.emory.edu
December 4, 2024 at 2:15 PM
Reposted by Enrico Velardi
On my way to @ash-hematology.bsky.social #ASH24 & sharing this starterpack for HCT, #CARTcells & #genetherapy - > 100 members DM/comment if I missed someone #bmtsm #mmsm #leusm #lymsm #sicklecell #mpnsm #medsky

go.bsky.app/7xxh8WW
December 5, 2024 at 12:32 PM
Reposted by Enrico Velardi
Here is out first attempt to understand #TCR #repertoire in human tissues -Tissue determinants of the human T cell receptor repertoire Around 6 million T cells profiled at #single #cell #level www.biorxiv.org/content/10.1...
Tissue determinants of the human T cell receptor repertoire
98% of T cells reside in tissues, yet nearly all human T cell analyses are performed from peripheral blood. We single-cell sequenced 5.7 million T cells from ten donors’ autologous blood and tonsils a...
www.biorxiv.org
November 15, 2024 at 2:13 PM
Very excited to write my first post and share our lab latest paper with this (renewed) community!
Big thanks to my lab and all co-authors for the huge effort and the collaborative opportunity!

www.nature.com/articles/s41...
Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease - npj Precision Oncology
npj Precision Oncology - Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease
www.nature.com
November 22, 2024 at 5:15 PM